Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Herpes simplex virus vectors for the nervous system.

C E Lilley1, R H Branston, R S Coffin

  • 1Dept. of Immunology & Molecular Pathology, UCL Medical School, The Windeyer Bldg., 46 Cleveland St., London, W1P 6DB, U.K.

Current Gene Therapy
|July 12, 2002
PubMed
Summary

Herpes simplex virus type 1 (HSV1) vectors offer potential for nervous system gene delivery due to neuronal tropism and latent infection capabilities. Overcoming toxicity and long-term expression challenges is key to their successful application.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oncolytic immunotherapy: an emerging new modality for the treatment of cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer.

British journal of cancer·2012
Same author

Hepatocyte growth factor incorporated into herpes simplex virus vector accelerates facial nerve regeneration after crush injury.

Gene therapy·2011
Same author

HSV Mutagenesis.

Methods in molecular medicine·2011
Same author

Science funding in low- and middle-income countries: the example of vaccine research.

Mucosal immunology·2009
Same author

Retrograde viral transduction of cortical pyramidal neurons from the spinal cord.

Restorative neurology and neuroscience·2008

Area of Science:

  • Neuroscience
  • Virology
  • Gene Therapy

Background:

  • Herpes simplex virus type 1 (HSV1) possesses characteristics suitable for gene delivery vectors targeting the nervous system.
  • These include neuronal tropism, a large genome for multiple gene insertions, and lifelong latent infection establishment.

Purpose of the Study:

  • To discuss the potential of HSV1 vectors for gene delivery to the nervous system.
  • To address challenges in developing effective HSV1 vectors, focusing on toxicity and sustained transgene expression.

Main Methods:

  • Review of recent advancements in overcoming HSV vector limitations.
  • Discussion of current and potential applications of HSV vector technology.

Main Results:

Related Experiment Videos

  • HSV vectors show promise for gene therapy in the nervous system.
  • Progress has been made in mitigating vector toxicity and achieving long-term transgene expression.

    • Conclusions:

    • Despite past challenges, recent progress enhances the viability of HSV1 vectors for neurological gene therapy.
    • Further development is expected to broaden the applications of this gene delivery technology.